Concepedia

Corinna Weinz

CW

Statistics

Publications

5

Citations

639

H-Index

5

Active since

1995

Affiliations

Bayer (Germany)(Current)

University of Münster

Corinna Weinz is an author at Bayer (Germany) specializing in drug metabolism, pharmacology, and drug disposition.

Publications per year

1995–2009

5

Publications

5

Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans

Corinna Weinz, Thomas Schwarz, Dagmar Kubitza et al. · Drug Metabolism and Disposition · 2009 · 375 citations

Medicine, Pharmacokinetics, Pharmacology +11

In Vitro Metabolism of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans

Dieter Lang, C. Freudenberger, Corinna Weinz · Drug Metabolism and Disposition · 2009 · 108 citations

Medicine, Biochemistry, Pharmacology +16

Pharmacokinetics of BAY 59-7939 – an oral, direct Factor Xa inhibitor – in rats and dogs

Corinna Weinz, Ulf Buetehorn, H.-P. Daehler et al. · Xenobiotica · 2005 · 102 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Investigation of the in vitro biotransformation and simultaneous enantioselective separation of thalidomide and its neutral metabolites by capillary electrophoresis

Corinna Weinz, Gottfried Blaschke · Journal of Chromatography B Biomedical Sciences and Applications · 1995 · 32 citations

Pharmacy, Biochemistry, Pharmaceutics +16

Investigation of the stereoselective in vitro biotransformation of glutethimide by high-performance liquid chromatography and capillary electrophoresis

Corinna Weinz, Gottfried Blaschke, Hans‐Martin Schiebel · Journal of Chromatography B Biomedical Sciences and Applications · 1997 · 22 citations

Pharmacy, Biochemistry, Pharmacology +9

1–5 of 5